Organisation paid for research Program year 2024 Source: CMS Open Payments

Trihealth Inc.

Neither a doctor nor a teaching hospital

Research payments

$59,168

28 payments

Through program year 2024, Trihealth Inc. is reported as receiving $59,168 in research payments, across 28 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$51,474	23
2023	Research	$90	2
2022	Research	$7,603	3

Breakdown

Who paid Research payments · program years 2022–2024

Atricure, Inc. $29,474 17 payments
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $22,000 6 payments
AstraZeneca Pharmaceuticals LP $7,603 3 payments
Abbott Laboratories $90 2 payments

Studies the money was for Research payments · program years 2022–2024

Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia $28,273 15 payments
Opt-Bb Women $22,000 6 payments
Dapagliflozin in Acute Decompensated Heart Failure $6,500 1 payment
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial $1,201 2 payments
This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the efficacy and safety of AZD4831 administered for up to 48 Weeks in participants with heart failure with left ventricular ejection fractio $1,103 2 payments
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants (CATALYST) $90 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.